|
Biropepimut-S
|
DB14816 |
[Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity).] |
|
Cobitolimod
|
DB14819 |
[Cobitolimod is under investigation in clinical trial NCT03178669 (The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis).] |
|
Osocimab
|
DB14818 |
[Osocimab is under investigation in clinical trial NCT03276143 (FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty).] |
|
PF-232798
|
DB14813 |
[PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).] |
|
Procalcitonin
|
DB14812 |
[Procalcitonin is under investigation in clinical trial NCT03440060 (Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPD).] |
|
Ginsenoside B2
|
DB14815 |
[Ginsenoside B2 is under investigation in clinical trial NCT00781534 (A Clinical Trial of Ginseng in Diabetes).] |
|
Lanabecestat
|
DB14814 |
[Lanabecestat is under investigation in clinical trial NCT03499041 (A Study of LY3314814 in Participants With Liver Impairment).] |
|
Isatuximab
|
DB14811 |
[Isatuximab is under investigation in clinical trial NCT02514668 (A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma).] |
|
AZD-1656
|
DB14810 |
[AZD-1656 is under investigation in clinical trial NCT00747175 (A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes).] |
|
2,4-Dihydroxybenzoic Acid
|
DB02839 |
|
|
1-Phenylcyclohexylamine
|
DB01506 |
|
|
O4-Sulfonylgalactose
|
DB02837 |
|
|
Tenamfetamine
|
DB01509 |
[An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. [PubChem]] |
|
3,4-Dihydro-2h-Pyrrolium-5-Carboxylate
|
DB02838 |
|
|
Alpha-D-Glucose 1,6-Bisphosphate
|
DB02835 |
|
|
1-Androstenediol
|
DB01503 |
|
|
Guanosine 5'-diphosphate 2'_3'-cyclic monophosphate
|
DB02836 |
|
|
Diampromide
|
DB01502 |
|
|
Etoxeridine
|
DB01505 |
|
|
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine
|
DB02833 |
|
